1,213
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population

, , , , &
Pages 181-186 | Received 17 May 2010, Accepted 25 Apr 2011, Published online: 11 Jul 2011

References

  • Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365–75.
  • WHO. WHO Collaborating Centre for Drug Statistics Methodology. 2008 [cited 2007]; available from: http://www.whocc.no/atcddd/
  • Pehrsson Å, Lindström E, Kohl E, Jarnehammar K, Hirsch C, Lönnebo M, . Läkemedelsgenomgångar på Kungsholmen och Norrmalm. Report No. 6504–02. Stockholm: Norra Stockholms läkemedelskommité; 2002 May 2002. [Drug revue in Kungsholmen and Norrmalm. Report No. 6504-02. Stockholm: Northern Stockholm Pharmaceutical Committee].
  • Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, . Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003;1:82–9.
  • Hanlon JT, Lindblad CI, Hajjar ER, McCarthy TC. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother 2003;1:38–43.
  • Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, . Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002;50:1962–8.
  • Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004;39:1731–8.
  • Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465–79.
  • Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001;49:277–83.
  • Björkman IK, Fastbom J, Schmidt IK, Bernsten CB. Pharmaceutical Care of the Elderly in Europe Research (PEER) Group, Drug–drug interactions in the elderly. Ann Pharmacother 2002;36:1675–81.
  • Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug–drug interac-tions in elderly nursing home residents in Helsinki, Finland: A cross-sectional study. Drugs Aging 2008;25:683–92.
  • Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatrics/IPA 2004r;16:61–74.
  • Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: A two-year prospective study. Am J Geriatr Psychiatry 2007; Feb 9.
  • Jedenius E, Wimo A, Stromqvist J, Andreasen N. A Swedish programme for dementia diagnostics in primary healthcare. Scand J Prim Health Care 2008;26:235–40.
  • Jedenius E, Wimo A, Stromqvist J, Jonsson L, Andreasen N. The cost of diagnosing dementia in a community setting. Int J Geriatric Psychiatry 2009;Aug 14.
  • Wettermark B, Hammar N, Fored CM. The new Swedish Prescribed Drug Register: Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–35.
  • Sweden SS. Population statistics 2000–5. Description of the population in Sweden. SCB. Stockholm: Statistics Sweden; 2008.
  • Fastbom J. [Increased consumption of drugs among the elderly results in greater risk of problems]. Lakartidningen 2001;98:1674–9.
  • Johnell K, Fastbom J, Rosen M, Leimanis A. Inappropriate drug use in the elderly: A nationwide register-based study. Ann Pharmacother 2007;41:1243–8.
  • Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: A natural history study. J Am Geriatr Soc 1996;44:1078–81.
  • Klarin I, Fastbom J, Wimo A. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: Comparison with an urban cohort. Pharmacoepidemiol Drug Saf 2003;12:669–78.
  • Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J. The Norwegian General Practice (NORGEP)criteria for assessing potentially inappropriate prescriptions to elderly patients: A modified Delphi study. Scand J Prim Health Care 2009;27:153–9.
  • Läkemedelsverket. Läkemedelsbehandling och bemötande vid Beteendemässiga och Psykiska Symtom vid Demenssjukdom – BPSD Swe MPA 2008. [Dementia societal cost and the number of people with dementia in Sweden 2005. Stockholm: National Board of Health and Welfare; 2007].
  • Johnell K, Fastbom J, Rosen M, Leimanis A. Low quality of drug use among the elderly: An analysis based on the national drug registry shows regional differences. Lakartidningen 2007;104:2158–62.
  • Hovstadius B, Astrand B, Petersson G. Assessment of regional variation in polypharmacy. Pharmacoepidemiol Drug Saf 2010;19:375–83.
  • Wimo A, Jonsson L, Johansson L. Demenssjukdomarnas samhällskostnader och antalet dementa i Sverige 2005. Stockholm: National Board of Health and Welfare; 2007.
  • Andren S, Elmstahl S. Effective psychosocial intervention for family caregivers lengthens time elapsed before nursing home placement of individuals with dementia: A five-year follow-up study. Int Psychogeriatrics/IPA 2008:1–16.
  • Brodaty H, Green A, Koschera A. Meta-analysis of psychosocial interventions for caregivers of people with dementia. J Am Geriatr Soc 2003;51:657–64.
  • Eloniemi-Sulkava U, Notkola IL, Hentinen M, Kivela SL, Sivenius J, Sulkava R. Effects of supporting community-living demented patients and their caregivers: A randomized trial. J Am Geriatr Socy 2001;49:1282–7.
  • Pitkala KH, Strandberg TE, Tilvis RS. Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial. Drugs Aging 2001;18:143–9.